Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RECQL | P46063 | 1/20 | 0.49 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.49 |
| ▸ | CYP19A1 | P11511 | 4/20 | 0.45 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.45 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.45 |
| ▸ | TYR | P14679 | 1/20 | 0.45 |
| ▸ | AR | P10275 | 2/20 | 0.41 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.41 |
| ▸ | MAOA | P21397 | 1/20 | 0.38 |
| ▸ | MAOB | P27338 | 1/20 | 0.38 |
| ▸ | PSMB5 | P28074 | 1/20 | 0.38 |
| ▸ | HTR2A | P28223 | 1/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.37 |
| ▸ | MAPT | P10636 | 1/20 | 0.37 |
| ▸ | RAB9A | P51151 | 1/20 | 0.37 |
| ▸ | AXL | P30530 | 1/20 | 0.36 |
| ▸ | CYP1A1 | P04798 | 1/20 | 0.36 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.36 |
| ▸ | CYP1B1 | Q16678 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28030289 | 0.89 | TDP1 (0.55) | RECQLTDP1CYP19A1PTGS1PTGS2 | |
| SCHEMBL128290 | 0.85 | AR (0.49) | TDP1PTGS1ARCYP3A4MAOA | |
| SCHEMBL28035038 | 0.83 | RECQL (0.49) | RECQLTDP1CYP19A1PTGS1PTGS2 | |
| SCHEMBL5082125 | 0.83 | AR (0.53) | RECQLTDP1CYP19A1PTGS1PTGS2 | |
| SCHEMBL5088610 | 0.82 | CYP19A1 (0.47) | CYP19A1ARCYP3A4MAOAMAOB | |
| SCHEMBL9067958 | 0.82 | AXL (0.43) | TDP1PTGS1ARCYP3A4MAOA | |
| SCHEMBL2283832 | 0.80 | CYP3A4 (0.49) | TDP1CYP19A1ARCYP3A4MAOA | |
| SCHEMBL6822731 | 0.79 | TDP1 (0.57) | RECQLTDP1CYP19A1PTGS1PTGS2 | |
| SCHEMBL677662 | 0.79 | TDP1 (0.57) | RECQLTDP1CYP19A1PTGS1PTGS2 | |
| SCHEMBL27571346 | 0.78 | AR (0.37) | ARCYP3A4MAOBALDH1A1AXL |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2367522-A2 | METHOD AND COMPOSITION FOR SKIN COLOR MODULATION | Unilever Plc, A Company Registered In England And Wales under company no. 41424 of Unilever House (GB) | 2011-09-28 | — | — | EP | disclosed |
| WO-2010072805-A2 | METHOD AND COMPOSITION FOR COLOR MODULATION | UNILEVER PLC (GB) | 2010-07-01 | — | — | WO | disclosed |
| US-20100158829-A1 | Method and Composition for Color Modulation | CONOPCO, INC., D/B/A UNILEVER (US) | 2010-06-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100158829-A1 | Method and Composition for Color Modulation | TYR, TH, COMT | RECQL 1808/4885TDP1 845/4885CYP19A1 2093/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.